Schonfeld Strategic Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-993
Closed -$188K 2432
2021
Q1
$188K Buy
993
+180
+22% +$31.6K ﹤0.01% 1535
2020
Q4
$114K Sell
813
-1,014
-56% -$150K ﹤0.01% 1431
2020
Q3
$299K Buy
1,827
+500
+38% +$88.9K 0.01% 1091
2020
Q2
$274K Buy
+1,327
New +$308K 0.01% 1024
2020
Q1
Sell
-2,673
Closed -$561K 1624
2019
Q4
$561K Buy
+2,673
New +$384K 0.01% 705
2019
Q2
Sell
-6,667
Closed -$581K 1320
2019
Q1
$581K Sell
6,667
-3,333
-33% -$244K 0.02% 655
2018
Q4
$606K Sell
10,000
-353
-3% -$24.6K 0.02% 603
2018
Q3
$838K Buy
+10,353
New +$794K 0.04% 465

Other funds holding MTEM

Schonfeld Strategic Advisors's MTEM Position: Q2 2021 in Review

Schonfeld Strategic Advisors sold out of Molecular Templates, Inc. (MTEM) in Q2 2021, closing a stake of 993 shares — an estimated $188K sold.

Schonfeld Strategic Advisors first reported a position in MTEM in Q3 2018 and held it in 8 quarters. The position peaked at $838K in Q3 2018. 89 funds tracked by Wall St. Rank hold MTEM as of Q2 2021.

  • Schonfeld Strategic Advisors reported no remaining Molecular Templates, Inc. position as of Q2 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 993 Molecular Templates, Inc. shares in Q2 2021, an estimated $188K.
  • Schonfeld Strategic Advisors first reported a position in Molecular Templates, Inc. in Q3 2018 and held it in 8 quarters.
  • Schonfeld Strategic Advisors's Molecular Templates, Inc. position peaked at $838K in Q3 2018.
  • 89 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.